tiprankstipranks
Ovid Therapeutics Inc (OVID)
NASDAQ:OVID
US Market
OVID
Ovid Therapeutics
RESEARCH TOOLSreports

Ovid Therapeutics (OVID) Income Statement

1,742 Followers

Ovid Therapeutics Income Statement

Last quarter (Q4 2025), Ovid Therapeutics's total revenue was $718.00K, an increase of 844.74% from the same quarter last year. In Q4, Ovid Therapeutics's net income was $9.66M. See Ovid Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.25M$ 566.00K$ 392.00K$ 1.50M$ 208.38M
Gross Profit
$ 6.95M$ 566.00K$ 392.00K$ 1.50M$ 208.38M
Operating Expenses
$ 49.39M$ 62.45M$ 59.67M$ 57.05M$ 84.17M
Depreciation and Amortization
$ 300.00K$ 613.00K$ 568.00K$ 1.38M$ 237.08K
EBITDA
$ -42.14M$ -57.77M$ -57.01M$ -54.17M$ 124.45M
Operating Income
$ -42.44M$ -61.88M$ -59.28M$ -55.55M$ 124.21M
Other Income/Expenses
$ 25.02M$ 35.45M$ 6.94M$ 1.38M$ -45.69K
Pretax Income
$ -17.41M$ -26.43M$ -52.34M$ -54.17M$ 124.16M
Net Income
$ -17.41M$ -26.43M$ -52.34M$ -54.17M$ 122.83M
Per Share Metrics
Basic EPS
$ -0.24$ -0.37$ -0.74$ -0.77$ 1.78
Diluted EPS
$ -0.24$ -0.37$ -0.74$ -0.77$ 1.76
Weighted Average Shares Outstanding
 73.74M 70.91M 70.58M 70.42M 67.48M
Weighted Average Shares Outstanding (Diluted)
 73.74M 70.91M 70.58M 70.42M 68.07M
Currency in USD

Ovid Therapeutics Earnings and Revenue History